Relapsed/Refractory Mantle Cell Lymphoma (MCL)
2 clinical trials · Condition
◉ Watch Relapsed/Refractory Mantle Cell Lymphoma (MCL)
| Record | Firm | Date |
|---|---|---|
| A Study of APG-3288 in Relapsed/Refractory Blood Cancers (NCT07424833) | Ascentage Pharma Group Inc. | 2026-08-01 |
| A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL) (NCT04398953) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-07-20 |
Track Relapsed/Refractory Mantle Cell Lymphoma (MCL) automatically
Every clearance here is in the API, with alerts when new ones post.